Company profile EVGN

Evogene Ltd
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:34:43.

After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0.
Evogene expected interest is significantly lower compared to previous quarter (-73.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201925
70
180.0% QoQ
43
-38.6% QoQ
116
169.8% QoQ
2020 31
24.0% YoY -73.3% QoQ
78
11.4% YoY 151.6% QoQ
238
453.5% YoY 205.1% QoQ
271
133.6% YoY 13.9% QoQ
2021 502
1519.4% YoY 85.2% QoQ
124
59.0% YoY -75.3% QoQ
142
-40.3% YoY 14.5% QoQ
168
-38.0% YoY 18.3% QoQ
2022 70
-86.1% YoY -58.3% QoQ
83
-33.1% YoY 18.6% QoQ
94
-33.8% YoY 13.3% QoQ
61
-63.7% YoY -35.1% QoQ
2023 37
-47.1% YoY -39.3% QoQ
73
-12.0% YoY 97.3% QoQ
43
-54.3% YoY -41.1% QoQ
190
211.5% YoY 341.9% QoQ
2024 22
-40.5% YoY -88.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Evogene search interestLast update: February 08 2024 22:34:42.
Correlation coefficient between keyword and revenue is -0.65
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:34:43.

The average 5 years interest of Evogene was 9.51 per week.
The last year interest of Evogene compared to the last 5 years has changed by -31.44%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 18.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene biology to provide analysis

Correlation between past revenue and Evogene biology search interest

There is not enough data for Evogene biology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene biology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene seed traits to provide analysis

Correlation between past revenue and Evogene seed traits search interest

There is not enough data for Evogene seed traits to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene seed traits to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene agricultural products to provide analysis

Correlation between past revenue and Evogene agricultural products search interest

There is not enough data for Evogene agricultural products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene agricultural products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene human microbiome to provide analysis

Correlation between past revenue and Evogene human microbiome search interest

There is not enough data for Evogene human microbiome to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene human microbiome to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene industrial applications to provide analysis

Correlation between past revenue and Evogene industrial applications search interest

There is not enough data for Evogene industrial applications to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene industrial applications to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene medical cannabis products to provide analysis

Correlation between past revenue and Evogene medical cannabis products search interest

There is not enough data for Evogene medical cannabis products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene medical cannabis products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene collaborations to provide analysis

Correlation between past revenue and Evogene collaborations search interest

There is not enough data for Evogene collaborations to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene collaborations to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene -stock -company to provide analysis

Correlation between past revenue and Evogene -stock -company search interest

There is not enough data for Evogene -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EVGN
Earnings date: 2024-03-07 After close
Company name: Evogene Ltd
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-10-20T08:00:00-04:00

PR Newswire
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL

2026-10-06T16:00:00-04:00

PR Newswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors

2026-09-30T07:15:00-04:00

PR Newswire
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance

2026-08-31T08:00:00-04:00

PR Newswire
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward

2026-08-25T07:00:00-04:00

PR Newswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees

2026-08-18T08:04:00-04:00

PR Newswire
Evogene Reports Second Quarter and First Half 2026 Financial Results

2026-08-14T07:00:00-04:00

PR Newswire
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation

2026-07-30T07:00:00-04:00

PR Newswire
Evogene Schedules Second Quarter 2026 Financial Results Release

2026-07-22T08:00:00-04:00

PR Newswire
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

2026-07-15T07:30:00-04:00

PR Newswire
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities

2026-07-08T07:00:00-04:00

PR Newswire
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery

2026-06-24T08:00:00-04:00

PR Newswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

2026-06-18T12:00:00-04:00

Earnings Call Transcripts
Earnings Call - EVOGENE LTD

2026-06-09T07:00:00-04:00

PR Newswire
Evogene to Present Its Pharma Division Achievements at the BIO International Convention

2026-06-02T07:00:00-04:00

PR Newswire
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica